Background: While sports participation is often associated with health benefits, a subset of athletes may develop impaired bone health. Bone stress injuries (BSIs) are a common overuse injury in athletes; site of injury has been shown to relate to underlying bone health in female athletes.
However, a subset of athletes of both sexes may experience adverse health consequences associated with sports participation, including development of bone stress injuries (BSIs). BSI is a form of overuse injury to bone that is characterized by localized bone pain and tenderness as a result of structural fatigue. These injuries exist on a continuum of severity, with mild injuries resulting in periosteal edema and with more severe injuries showing varying degrees of marrow edema and evidence of stress fracture. The medical concern is that this form of injury may eventually progress to a full fracture if not appropriately treated. Prior research in runners has identified annual incidence rates of BSIs of approximately 5% in adolescent runners and 20% in collegiate runners. 26, 28 In rates of stress fracture by athletic exposure among all high school sports, girls cross-country ranks first, and boys cross-country ranks third. 5 Risk factors for BSI in athletes are often multifactorial. Female athletes with impaired nutrition may experience menstrual dysfunction and low bone mineral density (BMD). 7, 20 Cumulative risk factors for the female athlete triad (henceforth, triad) have been shown to increase risk for BSI. 4, 23, 28 While most research identifying risk factors for impaired bone health and BSI has been conducted in female athlete populations, there has been increased recognition that a subset of male athletes may also experience impaired bone health and have unacceptably high rates of BSI. 25 Male athletes with impaired nutrition may experience a similar process to the triad, including reduction in gonadal hormones and resulting impaired bone health that could predispose to BSI. 20, 22 The current sports medicine position statements regarding the triad 7 and RED-S (relative energy deficiency in sport) 20 recognize nutrition as a key determinant to promoting skeletal health and injury prevention in athletes of both sexes.
In contrast to research in female athletes, limited investigations have been completed in male athletes to identify risk factors for BSI and low BMD. Fredericson et al 10 reported that male soccer players had higher BMD when compared with runners and sedentary controls at all sites tested, including whole body, lumbar spine (LS), and calcaneus. Tenforde et al 27 found that 9 of 42 male adolescent runners had BMD Z-scores -1. Additionally, investigators determined risk factors associated with impaired bone health: body mass index 17.5 kg/m 2 and the belief that being thinner leads to faster running performances. 27 A larger investigation of 69 male athletes participating in running, soccer, basketball, and volleyball sports found that runners had a higher prevalence of stress fracture and low BMD. Cumulative risk factors for low BMD (defined as BMD Z-score \-1.0) included prior stress fracture, weekly running mileage .30 miles, \85% expected body weight, and consuming \1 serving of calcium-rich food per day. 3 These studies collectively suggest that male runners with lower body weight and impaired nutrition may be at heightened risk for impaired bone health and BSI.
Optimizing skeletal health in the male athlete is currently limited by knowledge regarding what subset of male athletes with BSI is at elevated risk for low BMD and should have dual-energy x-ray absorptiometry (DXA) and further medical evaluation and management. However, research of female athletes suggests that the location of BSI may provide valuable information for determining which athletes are at increased risk for poor bone health. Marx et al 16 found that female athletes with stress fractures in bones with greater trabecular bone content were more likely to have low BMD when compared with athletes who had sustained stress fractures in locations with greater cortical bone content. In later work among female athletes in 16 National Collegiate Athletic Association Division I sports, Tenforde et al 23 found that BSI locations differed according to the triad risk assessment score. Low-risk athletes (ie, those with fewer identified biological risk factors for the triad and BSI) were more likely to have fractures in corticalrich locations. Of athletes in the low-risk category sustaining BSIs, 8 of 9 (89%) had injury in cortical-rich sites, including metatarsal (n = 4), tarsal navicular (n = 2), cuboid, talus, and ulna (each n = 1). In contrast, moderate-and high-risk athletes were at higher risk for prospective BSIs, particularly at sites with greater trabecular bone content. Moderate-or high-risk athletes were 4.5-fold more likely to sustain injuries at trabecular-rich sites; 8 of 16 (50%) sustained an injury in the sacrum (n = 6), ilium (n = 1), and calcaneus (n = 1). 23 To date, we are unaware of published research that has characterized the association of BSI anatomic location with low BMD in male athletes. Therefore, the aim of this case series is to explore the association of BSI by anatomic location and sport type with low BMD while accounting for other medical conditions that can influence bone health. As with female athletes, we hypothesized that male athletes with BSIs at sites with greater trabecular content would be more likely to have BMD Z-scores \-1.0 as compared with those having BSIs only at sites with more cortical content. We also postulated that athletes in running sports would be at greatest risk for having low BMD.
METHODS

Participant Selection
A chart review was performed to identify all male athletes who were referred to a sports endocrinology clinic for a metabolic bone health evaluation, including DXA, to assess BMD after development of 1 BSI sustained in the pelvis and/or lower extremities at a tertiary care center (Boston Children's Hospital) from January 2009 to November 2016. After identification of the initial athlete population, a more extensive chart review was performed to identify details for each athlete, including medical conditions, medications, sports type, and injury. Only athletes with a history of BSIs attributed to sports participation and without long-standing medical conditions or medications that influence bone health were included in this case series. Our institutional review board approved this study.
Bone Stress Injury
To be classified as a BSI, each athlete injury required physician diagnosis, anatomic site of injury, and radiologic confirmation. The anatomic site of injury was divided into 2 categories: trabecular-rich BSIs included anatomic location with higher trabecular bone content-sacrum, pelvis (ilium, ischium, and pubic ramus), femoral neck, and calcaneus; cortical-rich BSIs included bones composed of greater cortical bone content-femoral shaft, tibia, fibula, metatarsal, and tarsal navicular.
Bone Mineral Density
Each athlete included in this case series underwent BMD testing by DXA (Hologic QDR-Horizon A; Hologic, Inc). Anatomic sites of BMD acquisition included total body less head (TBLH) and LS or total hip, femoral neck, and LS. Resulting BMD values were standardized to reference values of BMD Z-scores with available age, male sex, and ethnicity normative values. We defined low BMD in male athletes as a BMD Z-score \-1.0, similar to a prior investigation of male athletes. 3 Male athletes with suspected advanced or delayed maturity based on history and/or physical examination also had a hand radiograph to determine bone age with the standards of Greulich and Pyle. 11 Where bone age differed from chronologic age, bone age was used to determine Z-score (n = 1). Each patient who underwent DXA at our institution before early 2014 had scans of the LS, total hip, and femoral neck. After mid-2014, all patients 19 years of age who underwent DXA at our institution had scans of the LS and TBLH based on recommendations of the International Society of Clinical Densitometry. 6 
Serum Vitamin D, Calcium, Testosterone, and Other Laboratory Values
Athlete chart review included recording any laboratory values obtained as part of the clinical evaluation of bone health. These included serum 25-hydroxy vitamin D, calcium, magnesium, phosphorus, thyroid-stimulating hormone, free thyroxine (free T4), parathyroid hormone, total testosterone and free testosterone, and 24-hour urine calcium:creatinine ratio.
Statistical Analysis
The data presented on athletes are largely descriptive. To characterize the association of BSI location to low BMD, athletes were grouped as follows:
(1) Trabecular-rich location of BSI is defined as the population of athletes who sustained at least 1 trabecular BSI. (2) Cortical-rich location of BSI refers to the population of athletes who sustained 1 BSI only in sites with high cortical content and had no prior identified BSI at a trabecular-rich anatomic location.
Categorical variables of low BMD based on athlete sport type and site of injury were compared with Fisher exact tests. Differences in serum values for laboratory measures between groups with low BMD were compared with 2-tailed Student t tests. Association of blood laboratory values to BMD Z-scores were characterized as continuous variables with analysis of variance. Statistical threshold of significance for each comparison was defined as P value \.05.
RESULTS
Initial chart review identified 35 male athletes who were referred for evaluation of BMD after 1 BSI. Subsequently, 4 athletes were excluded for the following conditions: chronic colitis and bowel resection, hyperthyroidism, constitutional short stature with growth hormone deficiency, and recent 12-month inactivity after osteochondritis dissecans surgery. Additionally, 3 athletes were excluded owing to exposure to medications known to influence bone health, including chemotherapy, selective serotonin reuptake inhibitors, and lithium. No athletes had received long-term bone antiresorptive agents (eg, bisphosphonates) or anabolic bone medications (eg, recombinant parathyroid hormone). No athletes included in this series had received long-standing or recent oral or injectable steroids. One patient was included who had a history of taking clomiphene, a selective estrogen receptor modulator, for 6 to 8 weeks 1 year before DXA. One athlete reported tobacco use (2.5 cigarettes per day), and 4 reported alcohol use (range, 3-8.5 alcohol equivalent drinks per week).
Data on the 28 male athletes who met criteria for inclusion in the case series are presented in Tables 1 and 2 . Overall, mean age at evaluation was 19.1 6 5.6 years old (range, 14-36 years old), and mean body mass index was 22.2 6 2.0 kg/m 2 . All participants were Caucasian. Most athletes participated in the sport of running (18 of 28) . Of these 28 athletes, 17 had sustained 1 BSI in cortical-rich regions only, including the tibia (n = 21), metatarsus (n = 5), fibula (n = 5), femur (n = 3), and tarsal navicular (n = 2). In contrast, 11 athletes had history of 1 trabecular-rich BSI. This included 7 athletes who had BSIs in trabecular-rich sites only, including the sacrum (n = 4), femoral neck (n = 4), pubic ramus (n = 2), calcaneus, ilium, and ischium (each n = 1). An additional 4 athletes who sustained BSIs in trabecular-rich sites also had a history of BSIs in 1 cortical-rich location (3 metatarsus, 3 tibia, and 1 sesamoid). On average, athletes with a history of BSIs in 1 trabecular-rich location had a similar number of total BSIs when compared with athletes who sustained BSIs only in cortical-rich locations (2.36 vs 2.11 total BSIs).
The demographics and anthropometric characteristics of each population of athletes separated by trabecular-(n = 11) and cortical-rich (n = 17) sites of BSIs are presented in Table 3 . Athletes with a history of trabecular-rich BSIs were older and had lower BMD Z-scores for LS and TBLH. One participant's data were adjusted for bone age. The total number of BSIs sustained was not different between the trabecular-and cortical-rich groups (2.1 vs 1.6, respectively; P = .10). No differences in other characteristics were identified between populations, including body mass index and 25-hydroxy vitamin D level. Vitamin D intake through supplement and/or multivitamin was reported in almost half of the cortical-rich BSI population (8 of 17) and nearly all of the trabecular-rich population (9 of 11).
Low BMD (defined as BMD Z-score \-1.0 measured in 1 anatomic site by DXA) was identified in 43% of all athletes (12 of 28). Most athletes who sustained 1 BSI in a trabecular-rich location (9 of 11) had low BMD. In comparison, only 18% of athletes with BSIs in cortical-rich locations had low BMD (3 of 17).
Athletes with trabecular-rich BSIs had a 4.6-fold increased risk for low BMD versus those with corticalrich BSIs only (P = .002; 95% CI, 2.91-151.41). Within sport type, runners had a 6.1-fold increased risk for low BMD compared with nonrunners (11 of 18 vs 1 of 10, P = .02; 95% CI, 1.46-137.30). Number of lower-extremity BSIs was not associated with risk for low BMD. , and magnesium (13 of 17) levels were within reference limits in the majority of patients in whom they were checked. Abnormal values were 0.1 to 0.6 mg/dL greater than the upper limit of reference for the various assays; however, further evaluation did not demonstrate a clinical significance, and the calcium, phosphorus, and magnesium levels did not correlate with BMD or demonstrate a relationship with fracture site. Total testosterone was evaluated in 4 patients (range, 310-631 ng/dL), and levels were in the lower range of reference for adult males (700 6 300 ng/dL).
DISCUSSION
Within our case series, 43% of male athletes met criteria for low BMD; athletes participating in the sport of running were highly represented within the population of athletes with low BMD. While the true prevalence of low BMD is b BMD values for this subject are corrected for bone age.
unknown in male athletes and within each sport, the high proportion of athletes with impaired bone health is concerning. Participation in weightbearing sports is typically associated with enhanced skeletal health. 24 However, our findings of impaired bone health primarily affecting runners are consistent with prior studies reporting that 19% to 40% of male runners evaluated had impaired bone health with BMD T-score or Z-score thresholds -1.0.
10,27
Athletes who sustained 1 BSIs in anatomic locations with higher trabecular bone content had a 4.6-fold increased prevalence of low BMD when compared with athletes with a history of BSIs localized to only a cortical-rich site. This finding is consistent with prior investigations by Marx et al, 16 who identified a 3.3-fold increased risk for low BMD in female athletes with stress fractures in trabecular-rich locations, and Nattiv et al, 21 who identified that BSIs in trabecular-rich locations in men and women required a longer healing time and were accompanied by lower BMD values than BSIs at cortical-rich sites. Additionally, in the study by Nattiv et al, 21 women who sustained trabecular-rich BSIs were more likely to exhibit disordered eating and oligomenorrhea/amenorrhea.
While our case series cannot determine the cause of lower BMD in those with BSIs in trabecular-rich regions versus those with BSIs in only cortical-rich bone regions, it is possible that factors related to the triad or RED-S (low-energy availability and suppressed gonadal hormones) modulate risk for BSI and observed lower BMD. In a study evaluating 175 adolescent and young adult (14-25 years old) female amenorrheic athletes, eumenorrheic athletes, and nonathletes, Ackerman and colleagues 1 reported that amenorrheic athletes had lower BMD and higher stress fracture risk than eumenorrheic athletes. Additionally, as compared with eumenorrheic athletes, amenorrheic athletes had less optimal measures of bone microstructure by high-resolution peripheral quantitative computed tomography and reduced estimates of bone strength, particularly driven by differences in cortical bone. 1 A separate publication reported that amenorrheic athletes had suboptimal trabecular morphology and alignment when compared with eumenorrheic athletes and nonathletes. 19 Specifically among amenorrheic athletes, those with a history of stress fracture had fewer trabecular plates, thinner trabecular plates, and suboptimal trabecular alignment at the nonweightbearing radius, as compared with those without a stress fracture history. 19 Similarly, bioavailable estradiol has been associated more closely with BMD than bioavailable testosterone in men 12 and male athletes. 2 Estrogens influence male skeletal homeostasis, and serum testosterone and estradiol levels are positively correlated. 13 As .80% of circulating estradiol in men is derived from aromatization of testosterone, 14 suppressed gonadal function may result in bone loss that could be due to androgen deficiency, estrogen deficiency, or both. In an important study by Finkelstein et al, 8 392 healthy men aged 20 to 50 years were administered goserelin acetate, a suppressor of gonadal steroid production. Participants were given various doses of testosterone replacement, and then approximately half received anastrozole, which suppresses conversion of androgens to estrogens. As testosterone dosage decreased, bone resorption increased, especially when aromatization to estradiol was suppressed. Spine BMD, measured by quantitative computed tomography, fell significantly in all testosterone replacement groups in which aromatization was suppressed, independent of testosterone dosage. This study firmly supported prior work suggesting that estradiol is more important than testosterone for the male skeleton overall, with estrogen deficiency having a more profound effect at cortical components at peripheral sites. 8 With limited studies of male athletes, further work is needed to determine if the relative contributions of estradiol and testosterone to cortical and trabecular bone are skeletal site dependent and whether these results hold true in male athletes with suppressed gonadal hormones associated with sports participation and nutritional status.
Characteristics of sports participation may also contribute to lower BMD observed among different sports. Endurance sports have been postulated to have a higher prevalence of low-energy availability associated with sports participation. 15 Other changes to the neuroendocrine axis, including reduced growth hormone sensitivity and elevated cortisol levels, may contribute to observed changes in bone health; these hormone assays were not obtained in our athletes. Influence of skeletal loading on bone density and strength cannot be determined in our case series but may also influence fracture risk by anatomic location.
While our findings are novel, the limitations need to be acknowledged. The study design identified association of sport type and BSI locations to low BMD but cannot fully describe the behaviors and other factors associated with such injury or bone health. Athletes included in this case series were referred to a sports medicine specialist with expertise in bone metabolism, and DXAs were obtained for patients when deemed clinically appropriate (ie, fracture and other medical history). These factors may have increased the prevalence of low BMD values observed. However, the athletes included in the case series were carefully selected to minimize the risk of bias introduced by medical conditions or medications that could influence bone health or fracture risk. Because this study reports DXA results of patients scanned over a duration of 7 years, changes in our institution's DXA protocols led to patients having different scanned regions. Before mid-2014, patients 19 years of age had LS and hip imaging; after mid-2014, patients in that age range had LS and TBLH. This was based on concerns regarding the reproducibility of DXA results at the hip region owing to variability in the development of skeletal landmarks affecting proper positioning. 17 While this variability is less of a concern in older adolescents, because our DXA protocols changed, we cannot compare all DXA sites among the population scanned. 17 In a study of male military recruits aged 17 to 26 years, age was inversely associated with stress fracture risk, although skeletal maturity and BMD were not assessed. 18 We cannot fully account for influence of age and skeletal maturity (stage of bone accrual) in our analysis. We controlled for vitamin D insufficiency and other hormones (including thyroid function, parathyroid hormone, and testosterone when available). Compared with the cortical-rich group, a greater proportion of athletes belonging to the trabecular-rich BSI group reported intake of supplemental vitamin D; the influence of supplemental vitamin D on our lack of measured differences in serum 25-hydroxy vitamin D levels between groups cannot be determined. Additionally, we did not have robust data on energy availability, full gonadal hormone panels, bone turnover markers, or detailed physical activity history. We did not have a cohort of athletes without a history of BSI for BMD comparison. Our case series cannot control for other behaviors within athlete populations that influence bone health. Finally, our sample size and age range may limit generalizing findings to the full population of male athletes.
Despite these limitations, our case series represents the largest population of male athletes with a history of BSI and DXA studied to date and is intended to advance our understanding of specific sports and fracture locations associated with a higher risk for impaired bone health. From our results, clinicians may want to consider obtaining DXA on male runners and other athletes who sustain BSIs in anatomic sites with higher trabecular bone content. We recommend using behavioral strategies to improve the health of male athletes, including multidirectional impact-loading activities and optimizing nutritional factors of appropriate energy intake and adequate calcium and vitamin D. 24, 25 Male athletes who learn of impaired bone health may be motivated to make behavioral changes, including improved nutrition and cross-training to improve bone health and decrease fracture risk. 9 Prospective studies in larger populations of male athletes to better identify the cause of low BMD and methods to modify injury risk are required in order to optimize treatment of male athletes.
In summary, we found that 43% of the 28 male athletes in our case series had BMD Z-score values \-1.0. Male runners and athletes who sustained BSIs in trabecularrich anatomic locations had an associated increased risk for low BMD. Screening DXA should be considered for those with trabecular-rich bone injuries, particularly runners and other at-risk athletes. Our findings suggest that more efforts are needed to better manage skeletal health in a subset of male athletes and to identify areas for future research to better understand and manage BSIs in male athletes.
